{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:03:01Z","timestamp":1793678581354,"version":"4.5.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH065635"],"award-info":[{"award-number":["MH065635"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03610-1","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:21:40Z","timestamp":1761808900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A prodrug targeting CIM6P\/IGF2R enhances memory in healthy mice and reverses deficits in an Angelman syndrome mouse model"],"prefix":"10.1038","volume":"15","author":[{"given":"Francesca","family":"Aria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Arp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-2728","authenticated-orcid":false,"given":"Emmanuel","family":"Prikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Goodwin-Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-2942","authenticated-orcid":false,"given":"Kiran","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Munari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlok","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-0018","authenticated-orcid":false,"given":"Cristina M.","family":"Alberini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"3610_CR1","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9:a028035.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3610_CR2","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen MG, Kim MO, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2018;10:a033118.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3610_CR3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.tins.2020.05.004","volume":"43","author":"I Parenti","year":"2020","unstructured":"Parenti I, Rabaneda LG, Schoen H, Novarino G. Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci. 2020;43:608\u201321.","journal-title":"Trends Neurosci"},{"key":"3610_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000343995","volume":"59","author":"D Bergman","year":"2013","unstructured":"Bergman D, Halje M, Nordin M, Engstr\u00f6m W. Insulin-like growth factor 2 in development and disease: a mini-review. Gerontology. 2013;59:240\u20139.","journal-title":"Gerontology"},{"key":"3610_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1357-2725(98)00048-X","volume":"30","author":"SD O\u2019Dell","year":"1998","unstructured":"O\u2019Dell SD, Day IN. Insulin-like growth factor II (IGF-II). Int J Biochem Cell Biol. 1998;30:767\u201371.","journal-title":"Int J Biochem Cell Biol"},{"key":"3610_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nature09667","volume":"469","author":"DY Chen","year":"2011","unstructured":"Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku D, et al. A critical role for IGF-II in memory consolidation and enhancement. Nature. 2011;469:491\u20137.","journal-title":"Nature"},{"key":"3610_CR7","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1038\/emboj.2011.293","volume":"30","author":"RC Agis-Balboa","year":"2011","unstructured":"Agis-Balboa RC, Arcos-Diaz D, Wittnam J, Govindarajan N, Blom K, Burkhardt S, et al. A hippocampal insulin-growth factor 2 pathway regulates the extinction of fear memories. EMBO J. 2011;30:4071\u201383.","journal-title":"EMBO J"},{"key":"3610_CR8","doi-asserted-by":"publisher","first-page":"9408","DOI":"10.1523\/JNEUROSCI.2700-12.2013","volume":"33","author":"Y Ouchi","year":"2013","unstructured":"Ouchi Y, Banno Y, Shimizu Y, Ando S, Hasegawa H, Adachi K, et al. Reduced adult hippocampal neurogenesis and working memory deficits in the Dgcr8-deficient mouse model of 22q11.2 deletion-associated schizophrenia can be rescued by IGF2. J Neurosci. 2013;33:9408\u201319.","journal-title":"J Neurosci"},{"key":"3610_CR9","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/npp.2014.69","volume":"39","author":"SA Stern","year":"2014","unstructured":"Stern SA, Kohtz AS, Pollonini G, Alberini CM. Enhancement of memories by systemic administration of insulin-like growth factor II. Neuropsychopharmacology. 2014;39:2179\u201390.","journal-title":"Neuropsychopharmacology"},{"key":"3610_CR10","doi-asserted-by":"publisher","first-page":"E3582","DOI":"10.1073\/pnas.1423989112","volume":"112","author":"A Shahmoradi","year":"2015","unstructured":"Shahmoradi A, Radyushkin K, Rossner MJ. Enhanced memory consolidation in mice lacking the circadian modulators Sharp1 and -2 caused by elevated Igf2 signaling in the cortex. Proc Natl Acad Sci USA. 2015;112:E3582\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3610_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neurobiolaging.2016.04.006","volume":"44","author":"AB Steinmetz","year":"2016","unstructured":"Steinmetz AB, Johnson SA, Iannitelli DE, Pollonini G, Alberini CM. Insulin-like growth factor 2 rescues aging-related memory loss in rats. Neurobiol Aging. 2016;44:9\u201321.","journal-title":"Neurobiol Aging"},{"key":"3610_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/aur.2418","volume":"14","author":"E Cruz","year":"2021","unstructured":"Cruz E, Descalzi G, Steinmetz A, Scharfman HE, Katzman A, Alberini CM. CIM6P\/IGF-2 receptor ligands reverse deficits in Angelman syndrome model mice. Autism Res. 2021;14:29\u201345.","journal-title":"Autism Res"},{"key":"3610_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2018.10.012","volume":"149","author":"M Pardo","year":"2019","unstructured":"Pardo M, Cheng Y, Sitbon YH, Lowell JA, Grieco SF, Worthen RJ, et al. Insulin growth factor 2 (IGF2) as an emergent target in psychiatric and neurological disorders. Review Neurosci Res. 2019;149:1\u201313.","journal-title":"Review Neurosci Res"},{"key":"3610_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tins.2023.03.007","volume":"46","author":"CM Alberini","year":"2023","unstructured":"Alberini CM. IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases. Trends Neurosci. 2023;46:488\u2013502.","journal-title":"Trends Neurosci"},{"key":"3610_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1017\/S1041610219000383","volume":"31","author":"L Xia","year":"2019","unstructured":"Xia L, Zhu X, Zhao Y, Yang G, Zuo X, Xie P, et al. Genome-wide RNA sequencing analysis reveals that IGF-2 attenuates memory decline, oxidative stress and amyloid plaques in an Alzheimer\u2019s disease mouse model (AD) by activating the PI3K\/AKT\/CREB signaling pathway. Int Psychogeriatr. 2019;31:947\u201359.","journal-title":"Int Psychogeriatr"},{"key":"3610_CR16","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.15252\/emmm.201404228","volume":"6","author":"M Pascual-Lucas","year":"2014","unstructured":"Pascual-Lucas M, Viana da Silva S, Di Scala M, Garcia-Barroso C, Gonz\u00e1lez-Aseguinolaza G, Mulle C, et al. Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice. EMBO Mol Med. 2014;6:1246\u201362.","journal-title":"EMBO Mol Med"},{"key":"3610_CR17","doi-asserted-by":"publisher","first-page":"e94287","DOI":"10.1371\/journal.pone.0094287","volume":"9","author":"TJ Mellott","year":"2014","unstructured":"Mellott TJ, Pender SM, Burke RM, Langley EA, Blusztajn JK. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer\u2019s disease model mice. PLoS One. 2014;9:e94287.","journal-title":"PLoS One"},{"key":"3610_CR18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1523\/JNEUROSCI.2010-17.2017","volume":"38","author":"AB Steinmetz","year":"2018","unstructured":"Steinmetz AB, Stern SA, Kohtz AS, Descalzi G, Alberini CM. Insulin-like growth factor II targets the mTOR pathway to reverse autism-like phenotypes in mice. J Neurosci. 2018;38:1015\u201329.","journal-title":"J Neurosci"},{"key":"3610_CR19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54781","volume":"9","author":"XW Yu","year":"2020","unstructured":"Yu XW, Pandey K, Katzman AC, Alberini CM. A role for CIM6P\/IGF2 receptor in memory consolidation and enhancement. Elife. 2020;9:e54781.","journal-title":"Elife"},{"key":"3610_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainresrev.2003.11.002","volume":"44","author":"C Hawkes","year":"2004","unstructured":"Hawkes C, Kar S. The insulin-like growth factor-II\/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system. Brain Res Brain Res Rev. 2004;44:117\u201340.","journal-title":"Brain Res Brain Res Rev"},{"key":"3610_CR21","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1007\/s12035-016-9849-7","volume":"54","author":"Y Wang","year":"2017","unstructured":"Wang Y, MacDonald RG, Thinakaran G, Kar S. Insulin-like growth factor-II\/Cation-independent mannose 6-Phosphate receptor in neurodegenerative diseases. Mol Neurobiol. 2017;54:2636\u201358.","journal-title":"Mol Neurobiol"},{"key":"3610_CR22","first-page":"443","volume":"15","author":"M El Haj","year":"2017","unstructured":"El Haj M, Roche J, Gallouj K, Gandolphe MC. Autobiographical memory compromise in Alzheimer\u2019s disease: a cognitive and clinical overview. Geriatr Psychol Neuropsychiatr Vieil. 2017;15:443\u201351.","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"key":"3610_CR23","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1093\/cercor\/bhab165","volume":"31","author":"G Concina","year":"2021","unstructured":"Concina G, Renna A, Milano L, Manassero E, Stabile F, Sacchetti B. Expression of IGF-2 receptor in the auditory cortex improves the precision of recent fear memories and maintains detailed remote fear memories over time. Cereb Cortex. 2021;31:5381\u201395.","journal-title":"Cereb Cortex"},{"key":"3610_CR24","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1080\/15548627.2020.1775393","volume":"17","author":"K Pandey","year":"2021","unstructured":"Pandey K, Yu XW, Steinmetz A, Alberini CM. Autophagy coupled to translation is required for long-term memory. Autophagy. 2021;17:1614\u201335.","journal-title":"Autophagy"},{"key":"3610_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.biopsych.2022.11.016","volume":"94","author":"F Aria","year":"2023","unstructured":"Aria F, Pandey K, Alberini CM. Excessive protein accumulation and impaired autophagy in the hippocampus of Angelman syndrome modeled in mice. Biol Psychiatry. 2023;94:68\u201383.","journal-title":"Biol Psychiatry"},{"key":"3610_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13578-021-00726-x","volume":"11","author":"Z Deng","year":"2021","unstructured":"Deng Z, Zhou X, Lu JH, Yue Z. Autophagy deficiency in neurodevelopmental disorders. Cell Biosci. 2021;11:214.","journal-title":"Cell Biosci"},{"key":"3610_CR27","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41380-024-02741-z","volume":"30","author":"A Ham","year":"2025","unstructured":"Ham A, Chang AY, Li H, Bain JM, Goldman JE, Sulzer D, et al. Impaired macroautophagy confers substantial risk for intellectual disability in children with autism spectrum disorders. Mol Psychiatry. 2025;30:810\u201324.","journal-title":"Mol Psychiatry"},{"key":"3610_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","volume":"125","author":"AM Blokhuis","year":"2013","unstructured":"Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777\u201394.","journal-title":"Acta Neuropathol"},{"key":"3610_CR29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19:983\u201397.","journal-title":"Nat Med"},{"key":"3610_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/15548627.2018.1432327","volume":"14","author":"V Valenzuela","year":"2018","unstructured":"Valenzuela V, Nassif M, Hetz C. Unraveling the role of motoneuron autophagy in ALS. Autophagy. 2018;14:733\u20137.","journal-title":"Autophagy"},{"key":"3610_CR31","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, et al. Autophagy in major human diseases. EMBO J. 2021;40:e108863.","journal-title":"EMBO J"},{"key":"3610_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg1925","volume":"9","author":"E Im","year":"2023","unstructured":"Im E, Jiang Y, Stavrides PH, Darji S, Erdjument-Bromage H, Neubert TA, et al. Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr(682)-phosphorylated APP betaCTF. Sci Adv. 2023;9:eadg1925.","journal-title":"Sci Adv"},{"key":"3610_CR33","doi-asserted-by":"publisher","first-page":"14975","DOI":"10.1074\/jbc.270.25.14975","volume":"270","author":"B Schmidt","year":"1995","unstructured":"Schmidt B, Kiecke-Siemsen C, Waheed A, Braulke T, von Figura K. Localization of the insulin-like growth factor II binding site to amino acids 1508-1566 in repeat 11 of the mannose 6-phosphate\/insulin-like growth factor II receptor. J Biol Chem. 1995;270:14975\u201382.","journal-title":"J Biol Chem"},{"key":"3610_CR34","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/emboj\/21.5.1054","volume":"21","author":"J Brown","year":"2002","unstructured":"Brown J, Esnouf RM, Jones MA, Linnell J, Harlos K, Hassan AB, et al. Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur. EMBO J. 2002;21:1054\u201362.","journal-title":"EMBO J"},{"key":"3610_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/(SICI)1099-0690(199902)1999:2<447::AID-EJOC447>3.0.CO;2-R","volume":"1999","author":"C Vidil","year":"1999","unstructured":"Vidil C, Mor\u00e8re A, Garcia M, Barragan V, Hamdaoui B, Rochefort H, et al. Synthesis and biological activity of phosphonate analogs of mannose 6-phosphate (M6P). Eur J Org Chem. 1999;1999:447\u201350.","journal-title":"Eur J Org Chem"},{"key":"3610_CR36","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1002\/1099-0690(200010)2000:20<3433::AID-EJOC3433>3.0.CO;2-I","volume":"2000","author":"S Vidal","year":"2000","unstructured":"Vidal S, Garcia M, Montero JL, Mor\u00e8re A. Synthesis and biological evaluation of two mannose 6-phosphate analogs. Eur J Org Chem. 2000;2000:3433\u20137.","journal-title":"Eur J Org Chem"},{"key":"3610_CR37","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1016\/j.bmc.2006.01.024","volume":"14","author":"A Jeanjean","year":"2006","unstructured":"Jeanjean A, Garcia M, Leydet A, Montero JL, Mor\u00e8re A. Synthesis and receptor binding affinity of carboxylate analogues of the mannose 6-phosphate recognition marker. Bioorg Med Chem. 2006;14:3575\u201382.","journal-title":"Bioorg Med Chem"},{"key":"3610_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fnagi.2014.00177","volume":"6","author":"JA Lim","year":"2014","unstructured":"Lim JA, Li L, Raben N. Pompe disease: from pathophysiology to therapy and back again. Front Aging Neurosci. 2014;6:177.","journal-title":"Front Aging Neurosci"},{"key":"3610_CR39","first-page":"2003","volume":"12","author":"GR Hankins","year":"1996","unstructured":"Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, et al. M6P\/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene. 1996;12:2003\u20139.","journal-title":"Oncogene"},{"key":"3610_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1023\/A:1009571417429","volume":"5","author":"SA DaCosta","year":"2000","unstructured":"DaCosta SA, Schumaker LM, Ellis MJ. Mannose 6-phosphate\/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate? J Mammary Gland Biol Neoplasia. 2000;5:85\u201394.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"3610_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1006\/excr.2000.5121","volume":"264","author":"C Osipo","year":"2001","unstructured":"Osipo C, Dorman S, Frankfater A. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors. Exp Cell Res. 2001;264:388\u201396.","journal-title":"Exp Cell Res"},{"key":"3610_CR42","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.2174\/092986707782794005","volume":"14","author":"M Gary-Bobo","year":"2007","unstructured":"Gary-Bobo M, Nird\u00e9 P, Jeanjean A, Mor\u00e8re A, Garcia M. Mannose 6-phosphate receptor targeting and its applications in human diseases. Curr Med Chem. 2007;14:2945\u201353.","journal-title":"Curr Med Chem"},{"key":"3610_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","volume":"584","author":"SM Banik","year":"2020","unstructured":"Banik SM, Pedram K, Wisnovsky S, Ahn G, Riley NM, Bertozzi CR. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature. 2020;584:291\u20137.","journal-title":"Nature"},{"key":"3610_CR44","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1021\/acsmedchemlett.2c00479","volume":"14","author":"CM Stevens","year":"2023","unstructured":"Stevens CM, Zhou Y, Teng P, Rault LN, Liao Y, Tang W. Development of oligomeric Mannose-6-phosphonate conjugates for targeted protein degradation. ACS Med Chem Lett. 2023;14:719\u201326.","journal-title":"ACS Med Chem Lett"},{"key":"3610_CR45","doi-asserted-by":"crossref","unstructured":"Arimilli MN, Kim CU, Dougherty J, Mulato A, Oliyai R, Shaw JP, et al. Synthesis, in vitro biological evaluation and oral bioavailability of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) prodrugs. Antivir Chem Chemother. 1997;8:557\u201364.","DOI":"10.1177\/095632029700800610"},{"key":"3610_CR46","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nrd1877","volume":"4","author":"E De Clercq","year":"2005","unstructured":"De Clercq E, Holy A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat Rev Drug Discov. 2005;4:928\u201340.","journal-title":"Nat Rev Drug Discov"},{"key":"3610_CR47","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0896-6273(00)80596-6","volume":"21","author":"YH Jiang","year":"1998","unstructured":"Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 1998;21:799\u2013811.","journal-title":"Neuron"},{"key":"3610_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0957-4166(99)00494-2","volume":"11","author":"RJ Tennant-Eyles","year":"2000","unstructured":"Tennant-Eyles RJ, Davis BG, Fairbanks AJ. Peptide templated glycosylation reactions. Tetrahedron-Asymmetry. 2000;11:231\u201343.","journal-title":"Tetrahedron-Asymmetry"},{"key":"3610_CR49","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1002\/slct.201701033","volume":"2","author":"S Traboni","year":"2017","unstructured":"Traboni S, Bedini E, Iadonisi A. Solvent-free one-pot diversified protection of saccharide polyols via regioselective tritylations. Chemistryselect. 2017;2:4906\u201311.","journal-title":"Chemistryselect"},{"key":"3610_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.carres.2015.04.010","volume":"412","author":"A Hofmann","year":"2015","unstructured":"Hofmann A, Sommer R, Hauck D, Stifel J, G\u00f6ttker-Schnetmann I, Titz A. Synthesis of mannoheptose derivatives and their evaluation as inhibitors of the lectin LecB from the opportunistic pathogen Pseudomonas aeruginosa. Carbohydr Res. 2015;412:34\u201342.","journal-title":"Carbohydr Res"},{"key":"3610_CR51","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1021\/jo00090a035","volume":"59","author":"C Jaramillo","year":"1994","unstructured":"Jaramillo C, Chiara JL, Martinlomas M. An effective strategy for the synthesis of 6-O-(2-Amino-2-Deoxy-Alpha-D-Glucopyranosyl)-D-Chiro and D-Myo-Inositol 1-Phosphate related to putative insulin mimetics. J Org Chem. 1994;59:3135\u201341.","journal-title":"J Org Chem"},{"key":"3610_CR52","unstructured":"Tojo G, Fernandez M. Oxidation of alcohols to aldehydes and ketones: a guide to current common practice. Basic Reactions in Organic Synthesis. Springer: New York, NY; 2006. pp. 1\u2013375."},{"key":"3610_CR53","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0040-4039(01)92575-4","volume":"18","author":"CE McKenna","year":"1977","unstructured":"McKenna CE, Higa MT, Cheung NH, McKenna MC. The facile dealkylation of phosphonic acid dialkyl esters by bromotrimethylsilane. Tetrahedron Lett. 1977;18:155\u20138.","journal-title":"Tetrahedron Lett"},{"key":"3610_CR54","unstructured":"Graham TH, Yu T, Waddell ST, McCauley JA, Stamford A, Liu W, et al. Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors. U.S. Patent US10624912B2, 2020."},{"key":"3610_CR55","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1016\/j.bmcl.2008.09.101","volume":"18","author":"A Jeanjean","year":"2008","unstructured":"Jeanjean A, Gary-Bobo M, Nird\u00e9 P, Leiris S, Garcia M, Mor\u00e8re A. Synthesis of new sulfonate and phosphonate derivatives for cation-independent mannose 6-phosphate receptor targeting. Bioorg Med Chem Lett. 2008;18:6240\u20133.","journal-title":"Bioorg Med Chem Lett"},{"key":"3610_CR56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1139\/v76-036","volume":"54","author":"GW Buchanan","year":"1976","unstructured":"Buchanan GW, Benezra C. Stereochemical dependence of C-13 shieldings and C-13-P-31 couplings in phosphonates of known geometry - is there a karplus-type relationship for P-C-C-C coupling. Can J Chem. 1976;54:231\u20137.","journal-title":"Can J Chem"},{"key":"3610_CR57","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0002-9440(10)63823-0","volume":"162","author":"AA Wylie","year":"2003","unstructured":"Wylie AA, Pulford DJ, McVie-Wylie AJ, Waterland RA, Evans HK, Chen YT, et al. Tissue-specific inactivation of murine M6P\/IGF2R. Am J Pathol. 2003;162:321\u20138.","journal-title":"Am J Pathol"},{"key":"3610_CR58","doi-asserted-by":"publisher","unstructured":"Kawakami Y, Sielski R, & Kawakami T Mouse body temperature measurement using infrared thermometer during passive systemic anaphylaxis and food allergy evaluation. JOVE. https:\/\/doi.org\/10.3791\/5839, 2018.","DOI":"10.3791\/5839"},{"key":"3610_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22020-6","volume":"8","author":"J Mei","year":"2018","unstructured":"Mei J, Riedel N, Grittner U, Endres M, Banneke S, Emmrich JV. Body temperature measurement in mice during acute illness: implantable temperature transponder versus surface infrared thermometry. Sci Rep. 2018;8:3526.","journal-title":"Sci Rep"},{"key":"3610_CR60","first-page":"13","volume":"43","author":"DM Newsom","year":"2004","unstructured":"Newsom DM, Bolgos GL, Colby L, Nemzek JA. Comparison of body surface temperature measurement and conventional methods for measuring temperature in the mouse. Contemp Top Lab Anim Sci. 2004;43:13\u20138.","journal-title":"Contemp Top Lab Anim Sci"},{"key":"3610_CR61","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"3610_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012;13:93\u2013110.","journal-title":"Cogn Process"},{"key":"3610_CR63","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0166-4328(98)00079-5","volume":"99","author":"SL Dix","year":"1999","unstructured":"Dix SL, Aggleton JP. Extending the spontaneous preference test of recognition: evidence of object-location and object-context recognition. Behav Brain Res. 1999;99:191\u2013200.","journal-title":"Behav Brain Res"},{"key":"3610_CR64","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuropharm.2016.12.009","volume":"116","author":"SL Ciarlone","year":"2017","unstructured":"Ciarlone SL, Wang X, Rogawski MA, Weeber EJ. Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an Angelman syndrome mouse model. Neuropharmacology. 2017;116:142\u201350.","journal-title":"Neuropharmacology"},{"key":"3610_CR65","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.brainresrev.2011.02.005","volume":"67","author":"R Lalonde","year":"2011","unstructured":"Lalonde R, Strazielle C. Brain regions and genes affecting limb-clasping responses. Brain Res Rev. 2011;67:252\u20139.","journal-title":"Brain Res Rev"},{"key":"3610_CR66","doi-asserted-by":"publisher","unstructured":"Guyenet SJ, Furrer SA, Damian VM, Baughan TD, La Spada AR, & Garden GA A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J Vis Exp. 2010:1787. https:\/\/doi.org\/10.3791\/1787.","DOI":"10.3791\/1787"},{"key":"3610_CR67","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.tibs.2009.07.003","volume":"34","author":"J Brown","year":"2009","unstructured":"Brown J, Jones EY, Forbes BE. Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure. Trends Biochem Sci. 2009;34:612\u20139.","journal-title":"Trends Biochem Sci"},{"key":"3610_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tics.2009.10.008","volume":"14","author":"MS Fanselow","year":"2010","unstructured":"Fanselow MS. From contextual fear to a dynamic view of memory systems. Trends Cogn Sci. 2010;14:7\u201315.","journal-title":"Trends Cogn Sci"},{"key":"3610_CR69","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1073\/pnas.1504809112","volume":"112","author":"C Mandel-Brehm","year":"2015","unstructured":"Mandel-Brehm C, Salogiannis J, Dhamne SC, Rotenberg A, Greenberg ME. Seizure-like activity in a juvenile Angelman syndrome mouse model is attenuated by reducing Arc expression. Proc Natl Acad Sci USA. 2015;112:5129\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3610_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0231-7","volume":"9","author":"M Sonzogni","year":"2018","unstructured":"Sonzogni M, Wallaard I, Santos SS, Kingma J, du Mee D, van Woerden GM, et al. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants. Mol Autism. 2018;9:47.","journal-title":"Mol Autism"},{"key":"3610_CR71","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1037\/h0075779","volume":"5","author":"SB Vincent","year":"1915","unstructured":"Vincent SB. The white rat and the maze problem: the introduction of a tactual control. J Anim Behav. 1915;5:175.","journal-title":"J Anim Behav"},{"key":"3610_CR72","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z. The Y-Maze for assessment of spatial working and reference memory in mice. Methods Mol Biol. 2019;1916:105\u201311.","journal-title":"Methods Mol Biol"},{"key":"3610_CR73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0149-7634(01)00041-0","volume":"26","author":"R Lalonde","year":"2002","unstructured":"Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev. 2002;26:91\u2013104.","journal-title":"Neurosci Biobehav Rev"},{"key":"3610_CR74","first-page":"235","volume":"19","author":"MR Wilson","year":"2023","unstructured":"Wilson MR, Satapathy S, Vendruscolo M. Extracellular protein homeostasis in neurodegenerative diseases. Nat Rev Neurol. 2023;19:235\u201345.","journal-title":"Nat Rev Neurol"},{"key":"3610_CR75","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.brainres.2015.07.002","volume":"1622","author":"Y Lee","year":"2015","unstructured":"Lee Y, Lee YW, Gao Q, Lee Y, Lee HE, Ryu JH. Exogenous insulin-like growth factor 2 administration enhances memory consolidation and persistence in a time-dependent manner. Brain Res. 2015;1622:466\u201373.","journal-title":"Brain Res"},{"key":"3610_CR76","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/cns.14160","volume":"29","author":"GS Fitzgerald","year":"2023","unstructured":"Fitzgerald GS, Chuchta TG, McNay EC. Insulin-like growth factor-2 is a promising candidate for the treatment and prevention of Alzheimer\u2019s disease. CNS Neurosci Ther. 2023;29:1449\u201369.","journal-title":"CNS Neurosci Ther"},{"key":"3610_CR77","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1021\/acs.jmedchem.7b00734","volume":"61","author":"Y Mehellou","year":"2018","unstructured":"Mehellou Y, Rattan HS, Balzarini J. The ProTide prodrug technology: from the concept to the clinic. J Med Chem. 2018;61:2211\u201326.","journal-title":"J Med Chem"},{"key":"3610_CR78","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0083-6729(08)00624-9","volume":"80","author":"HM El-Shewy","year":"2009","unstructured":"El-Shewy HM, Luttrell LM. Insulin-like growth factor-2\/mannose-6 phosphate receptors. Vitam Horm. 2009;80:667\u201397.","journal-title":"Vitam Horm"},{"key":"3610_CR79","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.omtm.2022.09.010","volume":"27","author":"Q Liang","year":"2022","unstructured":"Liang Q, Catalano F, Vlaar EC, Pijnenburg JM, Stok M, van Helsdingen Y, et al. IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy. Mol Ther Methods Clin Dev. 2022;27:109\u201330.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3610_CR80","doi-asserted-by":"publisher","first-page":"e1701398","DOI":"10.1002\/adhm.201701398","volume":"7","author":"E Dalle Vedove","year":"2018","unstructured":"Dalle Vedove E, Costabile G, Merkel OM. Mannose and Mannose-6-Phosphate receptor-targeted drug delivery systems and their application in cancer therapy. Adv Healthc Mater. 2018;7:e1701398.","journal-title":"Adv Healthc Mater"},{"key":"3610_CR81","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0026-0495(98)90007-5","volume":"37","author":"KR Duffy","year":"1988","unstructured":"Duffy KR, Pardridge WM, Rosenfeld RG. Human blood-brain barrier insulin-like growth factor receptor. Metabolism. 1988;37:136\u201340.","journal-title":"Metabolism"},{"key":"3610_CR82","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1749-6632.1993.tb26211.x","volume":"692","author":"WM Pardridge","year":"1993","unstructured":"Pardridge WM. Transport of insulin-related peptides and glucose across the blood-brain barrier. Ann N Y Acad Sci. 1993;692:126\u201337.","journal-title":"Ann N Y Acad Sci"},{"key":"3610_CR83","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1210\/endo.135.5.7525251","volume":"135","author":"RR Reinhardt","year":"1994","unstructured":"Reinhardt RR, Bondy CA. Insulin-like growth-factors cross the blood-brain-barrier. Endocrinology. 1994;135:1753\u201361.","journal-title":"Endocrinology"},{"key":"3610_CR84","doi-asserted-by":"publisher","first-page":"117862641984217","DOI":"10.1177\/1178626419842176","volume":"12","author":"MS Lewitt","year":"2019","unstructured":"Lewitt MS, Boyd GW. The role of insulin-like growth factors and insulin-like growth factor-binding proteins in the nervous system. Biochem Insights. 2019;12:1178626419842176.","journal-title":"Biochem Insights"},{"key":"3610_CR85","doi-asserted-by":"crossref","unstructured":"Kar S, Chabot JG, Quirion R. Quantitative autoradiographic localization of [I-125] insulin-like growth factor-I, [I-125] insulin-like growth factor-Ii, and [I-125] insulin-receptor binding-sites in developing and adult-rat brain. J Comp Neurol. 1993;333:375\u201397.","DOI":"10.1002\/cne.903330306"},{"key":"3610_CR86","doi-asserted-by":"publisher","first-page":"13200","DOI":"10.1523\/JNEUROSCI.0061-12.2012","volume":"32","author":"M Fern\u00e1ndez-Monreal","year":"2012","unstructured":"Fern\u00e1ndez-Monreal M, Brown TC, Royo M, Esteban JA. The balance between receptor recycling and trafficking toward lysosomes determines synaptic strength during long-term depression. J Neurosci. 2012;32:13200\u20135.","journal-title":"J Neurosci"},{"key":"3610_CR87","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1016\/j.neuron.2023.08.030","volume":"111","author":"K Pandey","year":"2023","unstructured":"Pandey K, Bessi\u00e8res B, Sheng SL, Taranda J, Osten P, Sandovici I, et al. Neuronal activity drives IGF2 expression from pericytes to form long-term memory. Neuron. 2023;111:3819\u201336e8.","journal-title":"Neuron"},{"key":"3610_CR88","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1523\/JNEUROSCI.0111-12.2012","volume":"32","author":"MJ Schmeisser","year":"2012","unstructured":"Schmeisser MJ, Baumann B, Johannsen S, Vindedal GF, Jensen V, Hvalby \u00d8C, et al. IkappaB kinase\/nuclear factor kappaB-dependent insulin-like growth factor 2 (Igf2) expression regulates synapse formation and spine maturation via Igf2 receptor signaling. J Neurosci. 2012;32:5688\u2013703.","journal-title":"J Neurosci"},{"key":"3610_CR89","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/372464a0","volume":"372","author":"ZQ Wang","year":"1994","unstructured":"Wang ZQ, Fung MR, Barlow DP, Wagner EF. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2\/Mpr gene. Nature. 1994;372:464\u20137.","journal-title":"Nature"},{"key":"3610_CR90","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrm1050","volume":"4","author":"P Ghosh","year":"2003","unstructured":"Ghosh P, Dahms NM, Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol. 2003;4:202\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3610_CR91","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz1466","volume":"6","author":"R Wang","year":"2020","unstructured":"Wang R, Qi X, Schmiege P, Coutavas E, Li X. Marked structural rearrangement of mannose 6-phosphate\/IGF2 receptor at different pH environments. Sci Adv. 2020;6:eaaz1466.","journal-title":"Sci Adv"},{"key":"3610_CR92","doi-asserted-by":"publisher","first-page":"34000","DOI":"10.1074\/jbc.M404588200","volume":"279","author":"LJ Olson","year":"2004","unstructured":"Olson LJ, Dahms NM, Kim JJ. The N-terminal carbohydrate recognition site of the cation-independent mannose 6-phosphate receptor. J Biol Chem. 2004;279:34000\u20139.","journal-title":"J Biol Chem"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03610-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03610-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03610-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:03:12Z","timestamp":1761814992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03610-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3610"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03610-1","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CMA, CJA, and DT are inventors of patents filed by NYU on the use of IGF2 receptor agonist ligands for the treatment of Angelman syndrome and autism and of memory and cognitive impairments. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}